Latest IBD Stories
The Westie Foundation of America (WFA) announced today preliminary findings in two major studies involving the health of West Highland White Terriers also known as Westies.
NEW YORK, July 12, 2011 /PRNewswire-USNewswire/ -- The Crohn's & Colitis Foundation of America today announced that it has opened enrollment for CCFA Partners, a comprehensive Internet-based registry designed to study thousands of patients with Crohn's disease or ulcerative colitis under a single research initiative.
UPPER SADDLE RIVER, N.J., June 14, 2011 /PRNewswire/ -- WellApps, Inc. announced today the newest release of GI Monitor, its symptom tracking app for (IBD) Crohn's and Ulcerative Colitis.
Researchers from Boston University School of Medicine (BUSM), along with clinicians from Boston Medical Center (BMC), have found gastroenterologist knowledge of the appropriate immunizations to recommend to the inflammatory bowel disease (IBD) patient is limited.
Patients with inflammatory bowel disease (IBD) have a greater risk of dying if they become infected with Clostridium difficile, according to a new study.
Patients admitted to hospital with inflammatory bowel disease face a sixfold greater risk of death if they become infected with Clostridium difficile, a new study has found.
The American College of Gastroenterology published a new evidence-based systematic review on the management of Inflammatory Bowel Disease (IBD) as a supplement to The American Journal of Gastroenterology (AJG) for April 2011, a special issue entirely dedicated to IBD.
On Sunday, April 10, 2011, the Philadelphia/Delaware Valley Chapter of the Crohnâ€™s & Colitis Foundation of America (CCFA) will hold its Annual Spring IBD Education Day at Thomas Jefferson University Hospital. Philadelphia, PA (Vocus/PRWEB) March 25, 2011 On Sunday, April 10, 2011, the Philadelphia/Delaware Valley Chapter of the Crohnâ€™s & Colitis Foundation of America (CCFA) will hold its Annual Spring IBD Education Day at Thomas Jefferson University Hospital. This free...
In the news release, NephRx Corp. Awarded New U.S. Patent for Oral Mucositis Agent NX002, issued 23-Mar-2011 by NephRx Corporation over PR Newswire, we are advised by the company that the original version should be disregarded. The complete, corrected release follows: NephRx Corp. Awarded U.S.
Children and adolescents growing up with inflammatory bowel disease (IBD) are less fit than their peers, says a study by researchers at McMaster University and the McMaster Children's Hospital.
- Of or relating to good digestion.